Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Accumulated Depreciation (2022 - 2025)

Historic Accumulated Depreciation for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to $45.6 million.

  • Century Therapeutics' Accumulated Depreciation rose 3930.67% to $45.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.6 million, marking a year-over-year increase of 3930.67%. This contributed to the annual value of $36.1 million for FY2024, which is 5788.6% up from last year.
  • Latest data reveals that Century Therapeutics reported Accumulated Depreciation of $45.6 million as of Q3 2025, which was up 3930.67% from $42.5 million recorded in Q2 2025.
  • Century Therapeutics' 5-year Accumulated Depreciation high stood at $45.6 million for Q3 2025, and its period low was $6.5 million during Q1 2022.
  • Moreover, its 4-year median value for Accumulated Depreciation was $22.8 million (2023), whereas its average is $24.7 million.
  • In the last 5 years, Century Therapeutics' Accumulated Depreciation surged by 15532.6% in 2023 and then surged by 3930.67% in 2025.
  • Over the past 4 years, Century Therapeutics' Accumulated Depreciation (Quarter) stood at $13.7 million in 2022, then surged by 67.25% to $22.8 million in 2023, then soared by 57.89% to $36.1 million in 2024, then increased by 26.49% to $45.6 million in 2025.
  • Its Accumulated Depreciation stands at $45.6 million for Q3 2025, versus $42.5 million for Q2 2025 and $39.1 million for Q1 2025.